Concepedia

Nnakelu Eriobu

NE

Statistics

Publications

4

Citations

88

H-Index

4

Active since

2022

Affiliations

Institute of Human Virology(Current)

University of California, Davis

National Institutes of Health

University of Colorado Denver

Medical Research Council

Nnakelu Eriobu is an author at Institute of Human Virology specializing in pharmacy, antiviral therapy, and infectious diseases.

ORCID

Publications per year

2022–2024

4

Publications

4

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

Eleftherios Mylonakis, Barnaby Edward Young, David M. Vock et al. · Annals of Internal Medicine · 2022 · 31 citations · Full text

, , +13

Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D2EFT): an open-label, randomised, phase 3b/4 trial

Gail Matthews, Simone Jacoby, Margaret Borok et al. · The Lancet HIV · 2024 · 31 citations · Full text

, , +14

Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19

Neil R. Aggarwal, Jacquie Nordwall, Dominique L. Braun et al. · Clinical Infectious Diseases · 2024 · 16 citations · Full text

, , +15

Associations Between Antiretroviral Regimen and Changes in Blood Pressure: Results From the D2EFT Study

Phyo Pyae Nyein, Kathy Petoumenos, Margaret Borok et al. · Clinical Infectious Diseases · 2024 · 10 citations · Full text

, , +12

1–4 of 4